Login to Your Account



Clinic Roundup


Tuesday, November 5, 2013
Biolinerx Ltd., of Jerusalem, received approval from the Finnish National Supervisory Authority for Welfare and Health to begin a Phase I/II trial of BL-7010 for celiac disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription